Rhumbline Advisers Trims Stake in Lam Research Corporation $LRCX

Rhumbline Advisers decreased its stake in Lam Research Corporation (NASDAQ:LRCX) by 1.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,561,919 shares of the semiconductor company’s stock after selling 33,901 shares during the quarter. Rhumbline Advisers’ holdings in Lam Research were worth $249,377,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of LRCX. Mufg Securities Americas Inc. raised its stake in Lam Research by 24.8% during the 2nd quarter. Mufg Securities Americas Inc. now owns 28,349 shares of the semiconductor company’s stock valued at $2,759,000 after purchasing an additional 5,627 shares during the period. Evelyn Partners Investment Management Services Ltd increased its position in Lam Research by 235,425.0% in the second quarter. Evelyn Partners Investment Management Services Ltd now owns 37,684 shares of the semiconductor company’s stock worth $3,629,000 after purchasing an additional 37,668 shares during the last quarter. Evelyn Partners Investment Management LLP raised its stake in Lam Research by 4,093.1% during the second quarter. Evelyn Partners Investment Management LLP now owns 1,216 shares of the semiconductor company’s stock valued at $113,000 after purchasing an additional 1,187 shares in the last quarter. AXQ Capital LP purchased a new stake in Lam Research during the second quarter valued at $553,000. Finally, Journey Strategic Wealth LLC lifted its position in Lam Research by 4.2% during the second quarter. Journey Strategic Wealth LLC now owns 6,957 shares of the semiconductor company’s stock valued at $677,000 after purchasing an additional 278 shares during the last quarter. 84.61% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Mizuho boosted their target price on shares of Lam Research from $162.00 to $170.00 and gave the stock an “outperform” rating in a report on Thursday, October 23rd. TD Cowen boosted their price objective on Lam Research from $145.00 to $170.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Oppenheimer set a $200.00 price objective on Lam Research and gave the company an “outperform” rating in a research report on Thursday, October 23rd. Barclays set a $142.00 price objective on Lam Research and gave the company an “equal weight” rating in a research note on Monday, October 20th. Finally, Susquehanna boosted their target price on Lam Research from $135.00 to $200.00 and gave the company a “positive” rating in a research report on Thursday, October 23rd. One research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $149.04.

Insider Activity at Lam Research

In other news, insider Ava Harter sold 9,010 shares of the firm’s stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the transaction, the insider directly owned 56,786 shares of the company’s stock, valued at approximately $8,942,091.42. This trade represents a 13.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction that occurred on Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the sale, the senior vice president directly owned 251,047 shares of the company’s stock, valued at $34,870,428.30. This represents a 17.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 102,608 shares of company stock worth $14,916,496. 0.31% of the stock is currently owned by corporate insiders.

Lam Research Trading Up 2.2%

LRCX opened at $142.65 on Friday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. The stock’s 50 day moving average price is $144.17 and its 200-day moving average price is $111.89. Lam Research Corporation has a one year low of $56.32 and a one year high of $167.15. The stock has a market cap of $179.17 billion, a price-to-earnings ratio of 31.42, a P/E/G ratio of 1.68 and a beta of 1.87.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.Lam Research’s revenue was up 27.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, equities analysts forecast that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be issued a $0.26 dividend. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. Lam Research’s dividend payout ratio is presently 22.91%.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.